Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Infection|August 24, 2007
Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited settingWeerawat Manosuthi, Achara Chaovavanich, Somsit Tansuphaswadikul, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 18, 2026
Factors associated with antibiotic prescription among patients with respiratory illness in Thailand: The potential impact of rapid influenza diagnostic testing in antimicrobial stewardshipChanakan Duanyai, Wanitchaya Kittikraisak, Visal Moolasart, et al.
Plos One|November 13, 2018
Emergence of genotype Cosmopolitan of dengue virus type 2 and genotype III of dengue virus type 3 in ThailandJuthamas Phadungsombat, Marco Yung-Cheng Lin, Narinee Srimark, et al.
Jac-Antimicrobial Resistance|January 11, 2023
Point prevalence survey of antibiotic use among hospitalized patients across 41 hospitals in ThailandSuvaporn Anugulruengkitt, Lantharita Charoenpong, Anond Kulthanmanusorn, et al.
International Journal of STD & AIDS|November 17, 2007
Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells/microLWeerawat Manosuthi, Somnuek Sungkanuparph, Somsit Tansuphaswadikul, et al.
Children (Basel, Switzerland)|June 27, 2024
Prevalence and Risk Factors of Healthcare-Associated Infections among Hospitalized Pediatric Patients: Point Prevalence Survey in Thailand 2021Visal Moolasart, Chaisiri Srijareonvijit, Lantharita Charoenpong, et al.
The Pediatric Infectious Disease Journal|April 18, 2025
Pharmacokinetics, Safety and Antiviral Activity of Rilpivirine in Antiretroviral-naïve Children With HIV ≥6 to <12 Years Old: Week 48 and Final Analysis of Cohort 2 From the Open-label, Phase 2 PAINT StudyJohan Lombaard, Visal Moolasart, Joseph Lutaakome, et al.
The Pediatric Infectious Disease Journal|August 19, 2025
Pharmacokinetics, Safety, Tolerability and Antiviral Activity of Switching to Oral Rilpivirine in Combination With Other Antiretroviral Therapy in Virologically Suppressed Children Living With HIV-1 Infection: Forty-eight-week Results From the Phase 2, Open-label, Single-arm, PICTURE StudyJohan Lombaard, Francis Ssali, Visal Moolasart, et al.
Pageof 2